Status:
COMPLETED
Protective Immunity Project 02
Lead Sponsor:
Emory University
Conditions:
Kidney Transplant
Immunology
Eligibility:
All Genders
18-59 years
Brief Summary
Influenza (Flu) vaccine is recommended for kidney transplant patients who are at least 6 months post-transplant. The influenza vaccine stimulates the immune system to builds protective antibodies agai...
Eligibility Criteria
Inclusion
- Male or female patients between 18 and 59 years of age
- Greater than six months post deceased or living donor renal transplant
- Patients capable of understanding the purposes and risks of the study, who can give written informed consent and who are willing to participate in and comply with the study.
- Patients with no known contraindications to flu vaccine (e.g. egg allergy, prior serious adverse reaction to flu vaccine, current febrile illness, marked leukopenia (WBC \< 2500 cells/ml)
- Women of childbearing potential must have a negative serum pregnancy test within 7 days of study enrollment and must not be breast-feeding.
Exclusion
- 1\. Patients with evidence of an active systemic infection
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00833651
Start Date
November 1 2006
End Date
October 1 2011
Last Update
November 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322